NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference
January 07 2022 - 1:02PM
Business Wire
Presentation to be available on January 10
NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that
produces the UroShield® and PainShield® Surface Acoustic Wave (SAW)
Portable Ultrasonic Therapeutic Devices, today announced it will be
featured as a presenting company at the H.C. Wainwright BioConnect
Virtual Conference to be held January 10-13, 2022.
Brian Murphy, Chief Executive Officer of NanoVibronix, will
provide an overview of the Company's business during the
presentation.
If you are an institutional investor, and would like to listen
to the company’s presentation, please click on the following link
(www.hcwevents.com/bioconnect) to register for the conference.
Investors may listen to the NanoVibronix presentation online
beginning on January 10 at 7 am ET via the following link:
https://journey.ct.events/view/1fb99e38-4b44-441c-9bbe-2941dd1583a8
The presentation recording will be available for 90 days from
the start of the conference.
About NanoVibronix, Inc.
NanoVibronix, Inc. (NASDAQ: NAOV) is a medical device company
headquartered in Elmsford, New York, with research and development
in Nesher, Israel, focused on developing medical devices utilizing
its patented low intensity surface acoustic wave (SAW) technology.
The proprietary technology allows for the creation of low-frequency
ultrasound waves that can be utilized for a variety of medical
applications, including for disruption of biofilms and bacterial
colonization, as well as for pain relief. The devices can be
administered at home without the assistance of medical
professionals. The Company’s primary products include PainShield®
and UroShield®, which are portable devices suitable for
administration at home without assistance of medical professionals.
Additional information about NanoVibronix is available at:
www.nanovibronix.com.
About H.C. Wainwright & Co.
H.C. Wainwright is a full‐service investment bank dedicated to
providing corporate finance, strategic advisory and related
services to public and private companies across multiple sectors
and regions. H.C. Wainwright & Co. also provides research and
sales and trading services to institutional investors. According to
Sagient Research Systems, H.C. Wainwright’s team is ranked as the
#1 Placement Agent in terms of aggregate CMPO (confidentially
marketed public offering), RD (registered direct offering) and PIPE
(private investment in public equity) executed cumulatively since
1998.
For more information visit H.C. Wainwright & Co. on the web
at www.hcwco.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220107005442/en/
Investor Contacts: Brett Maas, Managing Principal, Hayden
IR, LLC brett@haydenir.com (646) 536-7331
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From May 2024 to Jun 2024
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jun 2023 to Jun 2024